ERBB2 and gastric carcinoma: Most gastric carcinomas showing ERBB2 amplification were of the intestinal/glandular type (81.6% of all positive cases, P=0.007), but this genetic alteration was also observed in diffuse/isolated cells, and solid and mixed carcinomas (7.9, 5.3, and 5.3% of positive cases, respectively).